AMO DIPLOMAX/OPSYS CONSOLE

Unit, Phacofragmentation

ALLERGAN, INC.

The following data is part of a premarket notification filed by Allergan, Inc. with the FDA for Amo Diplomax/opsys Console.

Pre-market Notification Details

Device IDK971186
510k NumberK971186
Device Name:AMO DIPLOMAX/OPSYS CONSOLE
ClassificationUnit, Phacofragmentation
Applicant ALLERGAN, INC. 2525 DUPONT DR. Irvine,  CA  92612
ContactMonique M Heyninck-duran
CorrespondentMonique M Heyninck-duran
ALLERGAN, INC. 2525 DUPONT DR. Irvine,  CA  92612
Product CodeHQC  
CFR Regulation Number886.4670 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1997-04-01
Decision Date1997-06-13
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.